ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      CDSCO issues advisory to curb misleading promotion of...

CDSCO issues advisory to curb misleading promotion of...

The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers,...


      
      Semaglutide patent expiry opens over Rs 50,000 Crore opportunity

Semaglutide patent expiry opens over Rs 50,000 Crore opportunity

In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall...

      
      India and Obesity: SMSRC Insights Report reveals

India and Obesity: SMSRC Insights Report reveals

New Delhi [India], December 3: India stands at an inflexion point in its battle with obesity. For many years,...

      
      WHO issues a global guideline on the use of GLP-1 medicines

WHO issues a global guideline on the use of GLP-1 medicines

Obesity affects people in every country and was associated with 3.7 million deaths worldwide in 2024. Without...


      
      MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub

MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub

Bengaluru (Karnataka) [India], October 28: MrMed, India's largest online super-specialty pharmacy, has opened a...

      
      NoGuilt Fitness Launches Fitty GLP-1 Daily

NoGuilt Fitness Launches Fitty GLP-1 Daily

Chandigarh [India], October 24: NoGuilt Fitness, a homegrown health and wellness company focused on sustainable...

      
      CDSCO approves injection for Type 2 diabetes patients

CDSCO approves injection for Type 2 diabetes patients

In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals with Type 2...


      
      Lilly's orforglipron consistent with injectable GLP-1 medicines

Lilly's orforglipron consistent with injectable GLP-1 medicines

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule...

      
      Protein likely to help retain muscle mass without fat loss: Study

Protein likely to help retain muscle mass without fat loss: Study

The recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, has resulted in renewed...

      
      'Semaglutide' can be beneficial in protecting kidney function

'Semaglutide' can be beneficial in protecting kidney function

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective...

      
      Higher oral semaglutide dosage helps in weight loss

Higher oral semaglutide dosage helps in weight loss

Diabetes is a chronic disease that makes controlling blood sugar levels challenging. For many individuals, the...

      
      Doses of oral semaglutide improve blood sugar, weight loss: Study

Doses of oral semaglutide improve blood sugar, weight loss: Study

Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.